CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Technical Ops Officer sold 17,000 shares at $55.00 ($935,068)
- 4 Planned sale CHIEF OPERATING OFFICER sold 2,250 shares at an average $53.86 ($121,195)
- 4 Planned sale PRESIDENT AND CFO sold 10,000 shares at an average $53.89 ($538,879)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 18,198 shares at an average $55.63 ($1,012,375)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Planned sale PRESIDENT AND CFO sold 10,000 shares at an average $57.28 ($572,837)
- 4 Planned sale CHIEF OPERATING OFFICER sold 2,250 shares at an average $56.33 ($126,736)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 24,237 shares at an average $55.22 ($1,338,270)
Page 3 of 39 · 770 filings